The Effect of TRAIL on the Expression of Multidrug Resistant Genes MDR1, LRP and GST-π in Drug-Resistant Gastric Cancer Cell SGC7901/VCR

Background/Aims: To investigate the effect of tumor necrosis factor related apoptosis inducing ligand (TRAIL) on the expression of multidrug resistant genes MDR1, LRP and GST-pi in drug-resistant gastric cancer cell strain SGC7901/VCR, and discuss a potential mechanism that reverses the multidrug resistance of gastric cancer with TRAIL as the target point. Methodology: SGC7901/VCR cell strain was treated over 48h with TRAIL (50, 100,200 and 400 mu g/L, respectively). The expression of MDR1, LRP, GST-pi mRNA in different groups of gastric cell strains was tested by RT-PCR and the expression of P-gp, LRP and GST-pi by ELISA. Results: Under the action of TRAIL of different concentrations, different degrees of inhibition were observed in the expression of the mRNA and protein, and the difference from the reference group was statistically significant (p<0.01). Except for the insignificant inhibition degree of mRNA and protein in MDR1, LRP and GST-pi as compared between the 400 mu g/L and the 200 mu g/L group (p>0.05), the differences between other groups were all statistically significant (p<0.05). Conclusions: As preliminarily estimated from the results of the study, TRAIL is negatively correlated with drug-resistant genes. It is possible that TRAIL increases the apoptosis and growth inhibition of chemotherapy drug tumor cells by reducing the expression of drug-resistant genes MDR1, LRP and GST-pi, thereby participating in the reversion of the multidrug resistance of gastric cancer.